Several pre-clinical studies demonstrated that polydatin exerted therapeutic effects against an orthotopic metastatic tongue cancer model via inhibiting glucose 6 phosphate dehydrogenase (G6PD), and reduced tumor size and lymph node size and metastases [1]. Here, G6PD is linked to tongue cancer.